Enanta Pharmaceuticals (ENTA) FCF Margin Growth (1y) (2013 - 2026)
Enanta Pharmaceuticals (ENTA) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 10,799.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,799.00 |
| Dec 31, 2025 | 5,053.00 |
| Sep 30, 2025 | 14,702.00 |
| Jun 30, 2025 | 15,754.00 |
| Mar 31, 2025 | 3,157.00 |
| Dec 31, 2024 | 2,808.00 |
| Sep 30, 2024 | -4,025.00 |
| Jun 30, 2024 | 13,944.00 |
| Mar 31, 2024 | -9,479.00 |
| Dec 31, 2023 | 968.00 |
| Sep 30, 2023 | 1,084.00 |
| Jun 30, 2023 | -4,905.00 |
| Mar 31, 2023 | 5,513.00 |
| Dec 31, 2022 | -10,297.00 |
| Sep 30, 2022 | 428.00 |
| Jun 30, 2022 | -1,821.00 |
| Mar 31, 2022 | -11,822.00 |
| Dec 31, 2021 | -67.00 |
| Sep 30, 2021 | -2,501.00 |
| Jun 30, 2021 | -10,990.00 |